CNBC "Fast Money" Podcast Summary

Episode: Stocks Stage A Reversal... And The Latest Health Care M&A
Date: November 14, 2025
Host: Melissa Lee, with Tim Seymour, Bono, Steve Grasso, Julie Beal

Overview

This episode of "Fast Money" dives into a volatile trading week highlighted by an intraday market reversal, renewed Fed uncertainty, key earnings ahead—led by Nvidia and retail giants—major headlines from the health care M&A space, and policy news impacting tariffs and big tech. The roundtable dissects whether the week’s bounce changed sentiment, debates the outlook for consumer-facing stocks, breaks down Buffett’s bold buy in Alphabet, and analyzes the Merck-Sadara pharma deal. Additional topics include concerns over Alibaba after a U.S. security memo, tariff rollbacks, and strategic positioning ahead of next week’s market movers.

1. Stock Market Reversal: Volatility and Fed Uncertainty

[01:03-05:00]

• Market Action:

  • A sharp selloff early in the session (Nasdaq down ~2%, S&P & Dow also deep red, Bitcoin below $95k), major indices closed well off lows, Nasdaq eked out a gain.
  • High-momentum names like Super Micro, Robinhood, and Micron saw whipsaw action.

• Sentiment & Technicals:

  • Tim Seymour [02:27]:
    “The market feels more nervous than it did. … The rebound failed by the end of the day.”
  • Reversal “almost felt like that turnaround Tuesday on a Friday,” but comfort heading into next week is lacking despite technical bounces.

• Federal Reserve:

  • Fed hawks reemerged; December rate cut expectations moderated.
  • Bono [03:36]:
    “Tone and glide path are definitely at the forefront… You can’t expect there to be a straight line [in markets].”
  • Acknowledges suppressed volatility (VIX) and emphasizes caution as P/E expansion continues.

• Steve Grasso [05:20]:
  “Markets … don’t bottom on a Friday. … You don’t want to be into the weekend long.”

2. All Eyes on Nvidia and Retail Coming Up

[06:07-10:17]

• Nvidia’s Earnings as Market Catalyst:

  • Melissa Lee [06:07]:
    “If Nvidia had a wildly bullish outlook next week in terms of capex, etc—that could change things on a dime.”
  • Julie Beal [06:18]: Investors will seek “visibility and backlog … with or without federal backstops.”

• Retail Earnings Preview:

  • Concerns over consumer health despite low delinquencies and foreclosures.
  • Tim Seymour [07:12]:
    “I’m not worried about the valuations of the Mag 7 here … Meta’s in value territory.”
  • Steve Grasso [08:25]:
    “If you see the department stores, you see retail miss—they’re going to blame it on the government shutdown… I think they'll look past [the data].”

• Cautious Sentiment:

  • Discussion on the market’s need for a “real pullback” and whether the recent action “counts.”
  • Bono [09:48]:
    “The speed at which it happened and the swift change in sentiment is what caused people to raise their eyebrows.”
  • Retail guidance matters more than absolute numbers.

3. Retail Focus: Walmart vs Target, Consumer Health

[11:06-18:25]

• Walmart's Strength:

  • Joe Feldman (Telsey Advisory) praises Walmart’s digital transformation, AI integration, and operational efficiency, now targeting more affluent customers amid a challenging environment for lower-income consumers.
  • Feldman [11:46]:
    “They’re doing a really good job and have an opportunity to perform well … capturing that more affluent consumer at the same time.”

• Target’s Struggles & Value Play:

  • “Setup … is pretty good”—stores look better, expectations low, but it’s a “show me story.”
  • Feldman [13:10]:
    “New CEO Mike Fidelke … made some aggressive moves already to cut some staff at corporate.”

• Roundtable View:

  • Julie Beal [16:30]:
    “Oh, Walmart all day… They’re really able to capture this higher income consumer in a way that’s pretty unique.”
  • Bono [16:59]:
    “Walmart… but if you’re looking for juice in your portfolio, Target offers you a little more beta at this point.”
  • Tim Seymour [17:41]:
    “[The] spread differential [in valuation] is … a two and a half standard deviation event. Mean reversion says I own Target here.”

4. Berkshire Hathaway Moves: Alphabet Up, Apple Trimmed

[18:25-20:35]

• Leslie Picker [18:31]:
  “Berkshire Hathaway taking a new stake in Alphabet … 17.9 million shares… worth $4.3 billion at the end of the quarter… Berkshire also trimmed Apple in the quarter, selling 42 million shares, about 15% of its stake.”

• Alphabet now a top-10 Berkshire position.

• Opinions divided at major funds: some increasing Alphabet, others trimming.

• Tim Seymour [20:07]:
  “[The] move in Google … is unmistakable. Looks like really great stock picking.”

5. Alibaba in U.S. Crosshairs, China Tensions Rise

[22:33–25:59]

• Scathing Memo: White House memo (unverified, FT-sourced) alleges Alibaba helped Chinese military target the U.S. Alibaba denies claims; White House doesn’t comment.

• Tim Seymour [25:10]:
  “I am [an investor in Alibaba]. And I don’t like the headline… there are requirements for Chinese companies with the Chinese government.”

• Broader context: Chinese companies’ government ties fuel geopolitical investing risks.

6. Tariff Rollbacks: Political & Market Impact

[26:20–29:01]

• Eamon Javers [26:20]: White House announces exemptions to tariffs on hundreds of goods (coffee, bananas, avocados, tomatoes, mangoes, limes, beef, copper).

• Goal: address affordability, lower consumer costs ahead of midterms.

• Steve Grasso [27:45]: “Gas prices are down, egg prices are down. Midterms are coming up. You have to lower prices for everyone.”

• Julie Beal [28:33]:
  “They have raised a ton of revenue with tariffs and it’s very hard to walk away from that revenue.”

7. Apple: Defensive Beacon in Tech, But China & AI Debated

[30:34–33:54]

• Fresh Data: Reuters: iPhone sales in China +22% post-launch.

• Steve Grasso [31:23]:
  “The story has been out there for so long about China sales … everyone was sort of not shocked anymore… Apple late to the dance on AI ... is going to reap benefits.”

• Julie Beal [32:59]:
  “For them [Apple] it’s more about a brand than it is about the functionality ... they’ve positioned themselves as a real luxury brand but have the ability to do mass market volume.”

• Stickiness of iOS ecosystem counter-balances competitive threats, even without AI leadership.

8. Health Care M&A: Merck’s Sadara Deal and Sector Outlook

[34:21–40:55]

• Merck’s Action: $9.2 billion for Sadara Therapeutics (flu drug pipeline) to address Keytruda patent cliff.

• Jared Holz (Mizuho) [35:09]:
  “I’m not really sure they overpaid… the deal multiple seems pretty practical and in line with a lot of the recent deals. … I do think there’s a lot of urgency out there.”

• “String of pearls” strategy: Merck makes smaller targeted acquisitions rather than one giant buy.

• Holz [37:08]:
  “There are so many pharma companies in a similar position—Bristol, Sanofi, Amgen. I think they’re all going to be more acquisitive in 2026.”

• Julie Beal [39:40]:
  “I’m not comfortable [in small/mid-cap biotech]. … I like specialty companies that do medical devices… I can avoid patent cliffs and high competition.”

9. Boeing: Labor Deal Ends Strike, Road to Recovery

[41:26–42:24]

• Defense workers approve contract, ending a strike—stock battered during the dispute.
• Steve Grasso [41:27]:
  “Looking for 2026 return to profitability, return to generating free cash flow … it's a duopoly. I think you're going to be up in this stock if you hold it.”
• Tim Seymour: Notes that Boeing may have free cash flow accruing already, with upside in a volatile market.

10. Nvidia Earnings: The Next Big Market Moment

[42:24–45:25]

• Options Activity: Traders positioning bullishly ahead of Nvidia’s report; options market expects ±6% move (in line with recent quarters).

• Mike Co [42:57]:
  “I think [a buy-write options strategy] is probably a good way to play this going into the print.”

• Tim Seymour [44:16]:
  “Capex increases… don’t think there’s going to be a whole lot they can surprise us with on the downside.”

• Julie Beal [44:35]:
  “Mostly what we want is some commentary about how 2026 is shaping up and who are the biggest buyers.”

• Steve Grasso [44:45]:
  “Things don’t go grow completely to the sky and never come back. … I just think it’s got to stop at some point.”

Notable Quotes & Moments

• Melissa Lee [01:03]:
  “What should be the takeaway from today’s market action? From this week’s market action?”
• Tim Seymour [02:27]:
  “We do have a Fed that wants to communicate that December is not a fait accompli.”
• Julie Beal [32:59]:
  “If I cared about the functionality of my iPhone, I would have dumped it for a Samsung. It’s a much better product, like objectively. ... But I am so knit into their ecosystem and the branding and like the blue text bubble frankly that it's really, really hard to undo from that.”
• Jared Holz [38:31]:
  “If the M&A fervor continues at this pace, you certainly want to be long biotech into next year.”
• Tim Seymour [17:41]:
  "Mean reversion says I own Target here, actually own Wal Mart, but I do think you can own Target here and actually I own it for clients."
• Steve Grasso [27:45]:
  "Gas prices are down, egg prices are down. Midterms are coming up. You have to lower prices for everyone. Elections on Tuesday, number one thing on people's mind was affordability."
• Tim Seymour [28:13]:
  "You've removed the specific goods, but you've kept the companies under the ... spotlight. ... Political policy now is really the most important dynamic in tariffs."

11. Final Trades [45:40–46:28]

• Julie Beal: “Help Equity FSA growth is happening, and this is a nice hedge if inflation and interest rates go up.”
• Tim Seymour: “British Tobacco continues its breakout … a nice dip.”
• Bono: “Reduce a little bit of data, but still with continued upside…”
• Steve Grasso: “Comfortable owning some Boeing here.”

Programming Note:
Jim Cramer joins in-studio for Monday’s episode, promising a lively show.

Summary

This packed episode showcased the market’s split personality: nervous about valuations and Fed policy, yet not ready for a sustained selloff. Expectations for Nvidia’s report, plus retail giants' earnings, loom large for next week. Walmart’s shift upmarket steals the retail segment, while Target may offer value for contrarians. Big tech portfolio rebalancing is evident, especially with Berkshire’s moves in Alphabet and Apple. Meanwhile, tariffs are back in the headlines—politics and affordability blending with economics. Merck’s acquisition drive typifies the urgency in health care, where patent cliffs threaten steady cash cows. Underneath it all, uncertainty lingers, technical bounces feel fragile, and the next catalyst—earnings or macro—could sway sentiment swiftly.

For listeners and investors, the clear message: buckle up—volatility and opportunity will both stick around.